Literature DB >> 17591835

Adjuvant strategies in breast cancer: new prospectives, questions and reflections at the end of 2007 St Gallen International Expert Consensus Conference.

S Cinieri1, L Orlando, P Fedele, A Cusmai, M D'Amico, P Rizzo, M C Chetri.   

Abstract

Breast cancer detection and staging are constantly evolving as technologies improve. Breast cancer surgery is also undergoing continuous refinement, with the objective being to achieve optimal cosmetic results. Surgery has been combined with intraoperative radiation therapy to achieve the best local-disease control with minimal side-effects. The adjuvant strategy of treatment is a 'hot' issue in this 'scenario'. Every 2 years at St Gallen, a nice and cold town in the north of Switzerland, more of 4000 breast cancer experts arrive from every part of the world, to improve their knowledge in this issue. The Consensus Conference with the discussion of 40 international panelists is the zenith of the conference. This report provides a brief presentation and reflections, immediately at the end of the conference, with the objective being to stimulate ideas regarding what should be done tomorrow.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591835     DOI: 10.1093/annonc/mdm227

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  4 in total

1.  Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?

Authors:  Anna-Karin Falck; Mårten Fernö; Pär-Ola Bendahl; Lisa Rydén
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

2.  c-erbB-2 and the "triple-state" in early breast carcinomas.

Authors:  Efthimios Sivridis; Charilaos Stamos; Aliki Fiska; Nikolaos Nikolettos; Michael I Koukourakis; Alexandra Giatromanolaki
Journal:  Med Oncol       Date:  2009-06-23       Impact factor: 3.064

3.  Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer.

Authors:  Irfan Cicin; Hakan Karagol; Ufuk Usta; Atakan Sezer; Sernaz Uzunoglu; Rusen Alas-Cosar; Tarkan Yetisyigit; Kazim Uygun
Journal:  Med Oncol       Date:  2008-11-12       Impact factor: 3.064

4.  Strong association of a common dihydropyrimidine dehydrogenase gene polymorphism with fluoropyrimidine-related toxicity in cancer patients.

Authors:  Eva Gross; Birgit Busse; Matthias Riemenschneider; Steffi Neubauer; Katharina Seck; Hanns-Georg Klein; Marion Kiechle; Florian Lordick; Alfons Meindl
Journal:  PLoS One       Date:  2008-12-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.